ERNESTO ACOSTA: Open Payments
NPI 1871954339 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $385 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Dexcom, Inc. | 2 | $39 |
| Corcept Therapeutics | 2 | $31 |
| Amgen Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, Korlym, EVENITY, JEMPERLI, GVOKE HYPOPEN, TWIIST, TZIELD.
Industry payments across NC — which companies pay providers there.
